Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients

Diabetologia

Volumn 49, Issue 8, 2006, Pages 1777-1784

  Cheng, A Y S ^a   Kong, A P S ^a   Wong, V W S ^a   So, W Y ^a   Chan, H L Y ^a   Ho, C S ^a   Lam, C W K ^a   Tam, J S ^a   Chow, C C ^a   Cockram, C S ^a   Chan, J C N ^a   Tong, P C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Hepatitis B viral infection; Renal outcome; Type 2 diabetes

Indexed keywords

GLUCOSE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CHINESE; CHRONIC HEPATITIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SAMPLE SIZE; SCREENING TEST;

AGE OF ONSET; BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 33745774574     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0294-4     Document Type: Article

References (31)

1. Janus ED, Watt NM, Lam KS et al (2000) The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association. Diabet Med 17:741-745
2. No authors listed. (2003) Surveillance of viral hepatitis in Hong Kong - 2003 Update Report. Department of Health, Hong Kong SAR. http://www.chp.gov.hk/ files/pdf/hep_2005020301. pdf (accessed 25 August, 2005)
3. Kruszynska YT, McIntyre N (1991) Carbohydrate metabolism. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, pp 129-143
4. Allison ME, Wreghitt T, Palmer CR, Alexander GJ (1994) Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21:1135-1139
5. Caronia S, Taylor K, Pagliaro L et al (1999) Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30:1059-1063
6. Grimbert S, Valensi P, Levy-Marchal C et al (1996) High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 20:544-548
7. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A (2000) Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 75:355-359
8. Mason AL, Lau JY, Hoang N et al (1999) Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-333
9. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592-599
10. Shintani Y, Fujie H, Miyoshi H et al (2004) Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126:840-848
11. Antonelli A, Ferri C, Fallahi P et al (2005) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28:2548-2550
12. Knobler H, Schattner A (2005) TNF-a, chronic hepatitis C and diabetes: a novel triad. QJM 98:1-6
13. Crook ED, Penumalee S, Gavini B, Filippova K (2005) Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care 28:2187-2191
14. Soma J, Saito T, Taguma Y et al (2000) High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 11:690-699
15. Lao TT, Tse KY, Chan LY, Tam KF, Ho LF (2003) HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 26:3011-3016
16. Lo MK, Lee KF, Chan NN et al (2004) Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy. Diabetes Obes Metab 6:223-230
17. Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M (1993) Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med 10:371-377
18. Laakso M, Pyorala K (1985) Age of onset and type of diabetes. Diabetes Care 8:114-117
19. Mogensen CE, Vestbo E, Poulsen PL et al (1995) Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 18:572-581
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470
21. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
22. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV (2002) Ethnic disparities in diabetic complications in an insured population. JAMA 287:2519-2527
23. Wu AY, Kong NC, de Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48:17-26
24. No authors listed (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853
25. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75
26. Tong P, Lee K, So W et al (2004) Association of white blood cell counts with macrovascular and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216-222
27. Liaw YF, Tai DI, Chu CM, Chen TJ (1988) The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8:493-496
28. Liaw YF, Lin DY, Chen TJ, Chu CM (1989) Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver 9:235-241
29. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460-468
30. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK (2005) Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 43:38-44
31. Lai KN, Li PK, Lui SF et al (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324:1457-1463